RaySearch Laboratories to develop radiotherapy software for Varian
15 May 2007
Stockholm, Sweden. Varian Medical Systems and RaySearch Laboratories
(STO:RAYB) have signed a long-term strategic collaboration agreement in
which RaySearch will develop advanced radiation therapy treatment planning
software for integration into Varian’s Eclipse treatment planning system.
The collaboration involves developing a number of components, including
radiobiological optimization software, aimed at improving radiation
treatments. The first of these components is expected to be made available
to clinicians within the next year as part of Varian’s Eclipse treatment
planning system, which offers advanced software for the planning of
radiation oncology treatments. Radiobiological optimization enables
clinicians to use biological models such as probabilities relating to tumour
control and normal tissue complication rates in different parts of the body,
to optimize a treatment plan. This is different from more conventional
approaches that use standard dose prescriptions, which are surrogates for
outcomes, and less personalized to the patient’s specific disease and
anatomy.
“We are extremely excited about beginning a relationship with the world
leader in radiotherapy treatment,” says Johan Löf, president and chief
executive officer of RaySearch. “The collaboration will permit us to offer a
number of treatment planning solutions to Varian’s large installed base of
customers. “Using biological models further enhances our ability to design
treatments that eradicate the tumour while minimizing side effects.”
Jeff Amacker, director of Varian’s treatment planning software business,
adds, “RaySearch has developed some truly innovative solutions for advanced
radiation therapy planning and radiobiological optimization and we look
forward to making these capabilities available to our Eclipse customers.”
The Varian-RaySearch collaboration agreement involves radiobiological
evaluation and radiobiological optimization of treatment plans for standard
photon/electron radiotherapy, intensity modulated radiation therapy (IMRT)
and proton therapy, as well as optimization of conventional 3-D CRT. The
products will be seamlessly integrated into the Eclipse package.
To top
|